Minutillo S, Lupinc V, D'Agnolo B
Minerva Med. 1979 Dec 22;70(57):3919-24.
The Authors examine the antihypertensive effectiveness of the beta-adrenergic receptor blocking agents, according to their personal experience and a review of the bibliography. It is not cleared yet how these drugs reach their hypotensive effect. It is reasonable to assume however that several factors are involved: cardiac output, intravascular volume changes, plasma renin activity and peripheral resistance. Thirty patients suffering from essential hypertension not complicated by cardiac or renale failure were treated. Patients were allocated at random into one of three subsets of ten. In group A oxprenolol was given for 8 weeks and the dose was gradually increased up to 300 mgs daily. Oxprenolol was administered in combination with clortalidone in group B and with phentolamine in group C. A clinically satisfactory reduction in blood pressure was attained in no subset, despite the significant decrease of mean blood pressure. The blockade of beta-adrenergic receptors alone has proved to be less effective than the combined administration of oxprenolol and clortalidone or of oxprenolol and phentolamine. No differences were observed between the two combinations.
作者根据个人经验及文献综述,研究了β-肾上腺素能受体阻滞剂的降压效果。目前尚不清楚这些药物是如何产生降压作用的。不过,可以合理推测涉及几个因素:心输出量、血管内容量变化、血浆肾素活性和外周阻力。对30例患有原发性高血压且无心脏或肾脏衰竭并发症的患者进行了治疗。患者被随机分为三个每组10人的亚组。A组给予氧烯洛尔8周,剂量逐渐增加至每日300毫克。B组将氧烯洛尔与氯噻酮联合使用,C组将氧烯洛尔与酚妥拉明联合使用。尽管平均血压显著下降,但没有一个亚组的血压降低达到临床满意程度。事实证明,单独阻断β-肾上腺素能受体的效果不如氧烯洛尔与氯噻酮联合使用或氧烯洛尔与酚妥拉明联合使用。两种联合用药之间未观察到差异。